UCB finally gets a win with the FDA, scoring approval for myasthenia gravis drug Rystiggo
Fierce Pharma
JUNE 27, 2023
This has been a second straight year of regulatory struggles in the United States for UCB with one of the those issues revolving around the FDA needing additional time to
Let's personalize your content